Different intensities of glycaemic control for women with gestational diabetes mellitus

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 4, 2016, Pages

  Martis, Ruth ^a   Brown, Julie ^a   Alsweiler, Jane ^b   Crawford, Tineke J ^a   Crowther, Caroline A ^a,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CESAREAN SECTION; DIABETES, GESTATIONAL; FEMALE; HUMAN; HYPERGLYCEMIA; MACROSOMIA; NEWBORN; POSTPRANDIAL STATE; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); UTILIZATION;

CESAREAN SECTION; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; HUMANS; HYPERGLYCEMIA; INFANT, NEWBORN; POSTPRANDIAL PERIOD; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84979093414     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011624.pub2     Document Type: Review

References (82)

1. Snyder J, Morin I, Melzter S, Nadeau J. Gestational diabetes and glycaemic control: a randomized clinical trial. American Journal of Obstetrics and Gynecology 1998;178(1 Pt 2):S55.
2. Garner P, Okun N, Keely E, Wells G, Perkins S, Sylvain J, et al. A randomized controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: a pilot study. American Journal of Obstetrics and Gynecology 1997;177(1):190-5.
3. Keely EJ, Malcolm JC, Hadjiyannakis S, Gaboury I, Lough G, Lawson ML. Prevalence of metabolic markers of insulin resistance in offspring of gestational diabetes pregnancies. Pediatric Diabetes 2008;9(1):53-9.
4. Okun N. Gestational Diabetes Study. Personal communication 1994.
5. Ardilouze J-L. Glycemic objectives of women with gestational diabetes mellitus. ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 24 August 2015] 2015.
6. Crowther C. Optimal glycaemic targets for women with gestational diabetes: the randomised trial - TARGET. Australian New Zealand Clinical Trials Register (www.anzctr.org.au) [accessed 18 April 2015] 2015.
7. Hague W. Glucose targets in gestational diabetes pilot. Australian New Zealand Clinical Trials Register (www.anzctr.org.au) [accessed 5 March 2015] 2014.
8. Scifres C. Randomized controlled clinical pilot trial of intensive management for gestational diabetes. ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 25 August 2015] 2015.
9. American College of Obstetricians and Gynecologists Committee on Practice Bulletins - Obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 137, August 2013 (replaces Practice Bulletin Number 30, September 2001). Gestational diabetes mellitus. Obstetrics and Gynecology 2013;122(3 Pt 1):406-16.
10. American Dietetic Association. Medical Nutrition Therapy Evidence Based Guides for Practice: Nutrition Practice Guidelines for Gestational Diabetes Mellitus. Chicago, Illinois: American Dietetic Association, 2001.
11. American Diabetes Association. Standards of medical care in diabetes - 2013. Diabetes Care 2013;36(Suppl 1):S11-S63.
12. Alwan N, Tuffnell DJ, West J. Treatments for gestational diabetes. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2]
13. Athukorala C, Middleton P, Crowther CA. Intrapartum interventions for preventing shoulder dystocia. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD005543.pub2]
14. Athukorala C, Rumbold AR, Willson KJ, Crowther CA. The risk of adverse pregnancy outcomes in women who are overweight or obese. BMC Pregnancy Childbirth 2010;10:56.
15. Bellamy L, Casas J, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373:1773-9.
16. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birthweight, maternal obesity and gestational diabetes mellitus. Pediatrics 2005;115(3):e290-6.
17. Bottalico JN. Recurrent gestational diabetes: risk factors, diagnosis, management and implications. Seminars in Perinatology 2007;31:176-84.
18. Carolan M, Davey MA, Biro MA, Kealey M. Maternal age, ethnicity and gestational diabetes mellitus. Midwifery 2012;28(6):778-83. [DOI: 10.1016/j.midw.2011.08.014]
19. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. American Journal Obstetric Gynecology 1982;144:768-73.
20. Chamberlain C, McNamara B, Williams E, Yore D, Oldenburg B, Oats J, Eades S. Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand and the United States. Diabetes Metabolism Research Review 2013;29(4):241-56.
21. Cheung NW, Byth K. Population health significance of gestational diabetes. Diabetes Care 2003;26(7):2005-9.
22. Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, EnglandLJ, et al. Maternal obesity and risk of gestational diabetes mellitus: a meta-analysis. Diabetes Care 2007;30:2070-6.
23. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England Journal of Medicine 2005;352(24):2477-86.
24. The Diabetes Control and Complications Trial Research Group. Pregnancy outcomes in the Diabetes Control and Complications Trial (DCCT). American Journal of Obstetrics and Gynecology 1996;174:1343-53.
25. Devlieger R, Casteels K, Van Assche FA. Reduced adaptation of the pancreatic B cells during pregnancy is the major causal factor for gestational diabetes: current knowledge and metabolic effects on the offspring. Acta Obstetricia et Gynecologica Scandinavica 2008;87(12):1266-70.
26. Evans MJ. Diabetes and pregnancy: a review of pathology. British Journal of Diabetes & Vascular Disease 2009;9:201-6.
27. Farrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007;30(Suppl 2):S141-6.
28. Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive meta-analysis. British Journal of Psychiatry 2009;195:7-14.
29. GRADEpro GDT. GRADEpro Guideline Development Tool [Software]. McMaster University, (developed by Evidence Prime, Inc.), 2015. [Available from www.gradepro.org]
30. HAPO Study Cooperative Research Group. Hyperglycaemia and adverse pregnancy outcomes. New England Journal of Medicine 2008;358:1991-2002. [DOI: 10.1056/NEJMoa0707943]
31. Hernandez TL, Friedman JE, Van Pelt RE, Barbour LA. Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged?. Diabetes Care 2011;34(7):1660-8.
32. Hernandez T L. Glycemic targets in pregnancies affected by diabetes: historical perspective and future directions. Current Diabetes Reports 2015;15(1):565-72. [DOI: 10.1007/s11892-014-0565-2]
33. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
34. Hoffman L, Nolan C, Wilson JD, Oats JJN, Simmons D. The Australasian Diabetes in Pregnancy Society. Gestational diabetes mellitus management guidelines. Medical Journal of Australia 1998;169:93-7.
35. Health Services Executive. Guidelines for the Management of Pre-gestational and Gestational Diabetes from Pre-conception to the Post-natal Period. Dublin: Offices of the Nursing and Midwifery Services Director, 2010.
36. IADPSG Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33(3):676-82. [DOI: 10.2337/dc09-1848]
37. Kim SY, England L, Wilson HG, Bish C, Satten GA, Dietz P. Percentage of gestational diabetes mellitus attributable to overweight and obesity. American Journal of Public Health 2010;100(6):1047-52.
38. Kim SY, Saraiva C, Curtis M, Wilson HG, Troyan J, Sharma AJ. Fraction of gestational diabetes mellitus attributable to overweight and obesity by race/ethnicity, California, 2007-2009. American Journal of Public Health. 2013;103(10):e65-72. [DOI: 10.2105/AJPH.2013.301469]
39. Kleinwechter H, Schäfer-Graf U, Bührer C, Hoesli I, Kainer F, Kautzky-Willer A, et al. Gestational Diabetes Mellitus (GDM) diagnosis, therapy and follow-up care practice guideline of the German Diabetes Association (DDG) and the German Association for Gynaecology and Obstetrics (DGGG). Experimental and Clinical Endocrinology & Diabetes Journal 2014;122:395-405.
40. Kozhimannil KB, Pereira MA, Harlow BL. Association between diabetes and perinatal depression among low-income mothers. JAMA 2009;301(8):842-7. [DOI: 10.1001/jama.2009.201]
41. Krakowiak P, Walker CK, Bremer AA, Baker AS, Ozonoff S, Hansenm RL, et al. Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics 2012;129(5):e1121-8. [DOI: 10.1542/peds.2011-2583]
42. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. New England Journal of Medicine 2009;361(14):1339-48.
43. Langer O, Levy J, Brustman L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus- how tight is tight enough: small for gestational age versus large for gestational age?. American Journal of Obstetrics and Gynecology 1989;161(3):646-53.
44. Langer O, Rodriguez DA, Xenakis EMJ, McFarland MB, Berkus MD, Arredondo F. Intensified versus conventional management of gestational diabetes. American Journal of Obstetrics and Gynecology 1994;170(4):1036-47.
45. Lucas A, Morley R, Cole T. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. BMJ 1988;297(6659):1304-8.
46. McCance DR. Pregnancy and diabetes. Best Practice & Research Clinical Endocrinology & Metabolism 2011;25:945-58.
47. McCurdy C, Friedman J. Mechanisms underlying insulin resistance in human pregnancy and gestational diabetes mellitus. In: Kim K, Ferrara A editor(s). Gestational Diabetes During and After Pregnancy. London: Springer, 2010:125-38.
48. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the 5th International Workshop Conference on Gestational Diabetes Mellitus. Diabetes Care 2007;30(Suppl 2):S251-S260.
49. Metzger BE, Contreras M, Sacks DA, Watson W, Dooley SL, Foderaro M, et al. Hyperglycemia and adverse pregnancy outcomes. New England Journal of Medicine 2008;358(19):1991-2002.
50. Middleton P, Crowther CA, Simmonds L. Different intensities of glycaemic control for pregnant women with pre-existing diabetes. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD008540.pub3]
51. Mokdad AH, Ford ES, Bowman BA, Dieta WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes and obesity-related health risk factors. JAMA 2001;289(1):76-9.
52. Nankervis A, McIntyre HD, Moses R, Ross GP, Callaway L, Porter C, et al. Consensus Guidelines for the Testing and Diagnosis of Gestational Giabetes Mellitus in Australia. Sydney: Australasian Diabetes in Pregnancy Society, 2013.
53. National Diabetes Data Group. Classification. and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
54. New Zealand Ministry of Health. Screening, Diagnosis and Management of Gestational Diabetes in New Zealand: A Clinical Practice Guideline. Wellington, New Zealand: Ministry of Health, 2014.
55. National Institute for Health and Clinical Excellence (NICE). Diabetes in Pregnancy: Management of Diabetes and its Complications from Pre-Conception to the Postnatal Period. NICE Clinical Guideline 63. NICE, 2008.
56. National Institute for Health and Clinical Excellence (NICE) and National Collaborating Centre for Women and Children's Health Project Team. Diabetes in pregnancy: Management of diabetes and its complications from pre-conception to the postnatal period. NG3. NICE, 25 February 2015. [ISBN: 978-1-4731-0993-3]
57. Nicklas JM, Miller LJ, Zera CA, Davis RB, Levkoff SE, Seely EW. Factors associated with depressive symptoms in the early postpartum period among women with recent gestational diabetes mellitus. Maternal Child Health Journal 2013;17(9):1665-72. [DOI: 10.1007/s10995-012-1180-y]
58. Nomura Y, Marks DJ, Grossman B, Yoon M, Loudon H, Stone J, et al. Exposure to gestational diabetes mellitus and low socio-economic status: effects on neurocognitive development and risk of attention—deficit hyperactivity disorder in offspring. Archives of Pediatrics and Adolescent Medicine 2012;166:337-43.
59. Ornoy A. Growth and neurodevelopment outcome of children born to mothers with pregestational and gestational diabetes. Pediatric Endocrinology Reviews 2005;3(2):104-13.
60. Ornoy A. Prenatal origin of obesity and their complications: Gestational diabetes, maternal overweight and the paradoxical effects of fetal growth restriction and macrosomia. Reproductive Toxicology 2011;32:205-12.
61. Ornoy A, Reece EA, Pavlinkova G, Kappen C, Miller RK. Effect of maternal diabetes on the embryo, fetus, and children: Congenital anomalies, genetic and epigenetic changes and developmental outcomes. Birth Defects Research Part C: Embryo Today: Reviews 2015;105(1):53-72. [DOI: 10.1002/bdrc.21090]
62. Oteng-Ntim E, Varma R, Croker H, Poston L. Lifestyle interventions for overweight and obese pregnant women to improve pregnancy outcome: systematic review and meta-analysis. BMC Medicine 2012;10:47. [DOI: 10.1186/1741-7015-10-47]
63. Page KA, Romero A, Buchanan TA, Xiang AH. Gestational diabetes mellitus, maternal obesity and adiposity in offspring. Journal of Pediatrics 2014;164(4):807-10. [DOI: org/10.1016/j.jpeds.2013.11.063]
64. Pedersen J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinologica 1954;16(4):330-42.
65. Prutsky GJ, Domecq JP, Wand Z, Carranza Leon BG, Elraiyah T, Nabhan M, et al. Glucose targets in pregnant women with diabetes: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2013;98(11):4319-24. [DOI: 10.121/jc2013-2461]
66. Ragnarsdottir L, Conroy S. Development of macrosomia resulting from gestational diabetes mellitus: physiology and social determinants of health. Advanced Neonatal Care 2010;10(1):7-12.
67. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
68. Rosenberg TJ, Garbers S, Lipkind H, Chiasson MA. Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: Differences among four racial/ethnic groups. American Journal of Public Health 2005;95(9):1545-51.
69. Rowlands I, Graves N, de Jersey S, McIntyre HD, Gallaway L. Obesity in pregnancy: outcomes and economics. Seminars in Neonatal & Fetal Medicine 2010;15:94-9.
70. Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE, et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 2012;35(3):526-8. [DOI: 10.2337/dc11-1641]
71. Schneider S, Bock C, Wetzel M, Maul H, Loerbroks A. The prevalence of gestational diabetes in advanced economies. Journal of Perinatal Medicine 2012;40(5):511.
72. Schünemann H, Brożek J, Guyatt G, Oxman A, (editors). GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations. Vol. October up-dated version, The GRADE Working Group, 2013. [Available from www.guidelinedevelopment.org/handbook]
73. SIGN (Scottish Intercollegiate Guidelines Network). Management of Diabetes: A National Clinical Guideline. Edinburgh, Scotland: SIGN and Healthcare Improvement Scotland, 2014 updated. [URL: www.sign.ac.uk]
74. Slining M, Adiar LS, Goldman BD, Borja JB, Bentley M. Infant overweight is associated with delayed motor development. Journal of Pediatrics 2010;157(1):20-5.e1.
75. Suman Rao PN, Shashidhar A, Ashok C. In utero fuel homeostasis: Lessons for a clinician. Indian Journal of Endocrinology and Metabolism 2013;17(1):60-8.
76. Thompson D, Berger H, Feig D, Gagnon R, Kader T, Keely E, et al. Clinical Practice Guidelines: Diabetes and pregnancy. Canadian Journal of Diabetes 2013;37:S168-S183.
77. Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obesity Reviews 2009;10(2):194-203.
78. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Vol. Part 1: Diagnosis and Classification of Diabetes Mellitus, Geneva, Switzerland: World Health Organisation, 1999.
79. World Health Organization. Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. WHO/NMH/MND/13.2. Geneva, Switzerland: World Health Organization, 2013.
80. Wilcox G. Insulin and insulin resistance. Clinical Biochemistry Review 2005;26(5):19-39.
81. Young BC, Ecker JL. Fetal macrosomia and shoulder dystocia in women with gestational diabetes: risks amenable to treatment?. Current Diabetes Reports 2013;13(1):12-8.
82. Zhang C. Risk factors for gestational diabetes: from an epidemiological standpoint. In: Kim C, Ferrara A editor(s). Gestational Diabetes During and After Pregnancy. London: Springer, 2010:71-81.